@TheBHF funds more than 50% of cardiovascular research in the UK, leading to major advances in the fight against heart and circulatory disease. I will be cycling approximately 100km #L2B2025 on 15th June to raise funds for this amazing charity.

This editorial by @MichaelJoner3 & @dmylotte discusses new insights from van den Dorpel et al. on post-TAVI gradients: invasive >10 mmHg predicts mortality, while echo-derived values may mislead due to pressure recovery. #TAVI #CardioTwitter https://t.co/q0kWHFdCHy

Bioprosthetic vs Mechanical #AorticValve Replacement: The debate rages on! 🏥 This new study suggests mechanical may be the way to go for younger patients. Where do you stand? 🤔 🔗 Full #JACC study: https://t.co/nMtcKmeSsA

New platforms for transcatheter tricuspid valve replacement 🔗 https://t.co/J5TC0VGUgA Watch 📺 two advanced cases of symptomatic massive tricuspid regurgitation treatment. Key moments, from imaging analysis to procedural steps, highlight different techniques for you to

🔥 #PCRLV 🇬🇧 2024 Late-breaking Trials: Spotlight on TRISCEND II A study to ascertain whether Transcatheter Valve Replacement improves outcomes in symptomatic severe tricuspid regurgitation Outcome 📊: TTVR was superior to medical therapy for the primary composite outcome in

Good morning, #Cardiotwitter, it's time for Day 2⃣ of PCR London Valves #PCRLV 🇬🇧 On the menu today: 🏥3 LIVE Educational cases 🧑🏼‍⚕️Kick-off of the NAP programme 🔎#Tricuspid #TEER - The fundamentals 🖼️Hands-on mitral valve #imaging 🫀Simulation: Transseptal puncture and left

How do I manage the complexity of multivalve disease ? @drtpatterson and @PhilippLurz share their approach to treating patients with multiple valve issues (aortic stenosis, mitral regurgitation, tricuspid regurgitation...) and discuss strategies for deciding which valve to

#TAVI: From simple to complex, from stenosis to regurgitation View the replay of this LIVE case, now chapterised by @MartineGilard to enhance your educational experience: https://t.co/r8Jmlud8Hs Operators: Simon Redwood & @drtpatterson Procedural analyst @CCook_MD Key

New-onset breathlessness following bioprosthetic #SAVR. View part 1 of this new case shared by @drtpatterson & participate in the poll 📊 to show if you can determine the cause of this patient's symptoms! What would your treatment strategy be? https://t.co/xGk3dNhiIw

Now CME accredited! View 🔎 part 2 of this case by @drtpatterson on new-onset breathlessness following bioprosthetic SAVR, including an expert review by Simon Redwood. How would you treat? https://t.co/xGk3dNyTA4 #TAVR #CardioEd

#ICYMI here's the part 2 of this case by @drtpatterson on new-onset breathlessness following bioprosthetic SAVR, including an expert review by Simon Redwood. It's now CME accredited!

ACCESS-TAVI: Comparison 📊 of strategies for vascular ACCESS closure after transcatheter aortic valve implantation Read the #EAPCI/PCR Journal Club review ✍️ by @sbrugaletta of this trial presented by @TRheude at #TCT2024 and published in the European Heart Journal

Join us at #PCRLV 24 we have a dedicated NAP program for you! This year follow the patient care pathway from referal to discharge. We have a dedicated NAP room so its easy to find us @pcronline @denisamuraru @ABeneduceMD @HawranekMichal @SABOURETCardio

Love this time of year when #EuroPCR submissions are launched. Will we see you in Paris? @CuissetDr @NievesGonzalo1

Here we go 🚀: the moment we have all been waiting for! Submissions for #EuroPCR 2025 are open. Find out more about the many reasons why you should submit your work for the World-Leading Course in interventional cardiovascular medicine

Edge-to-edge repair for primary #mitral regurgitation: the good, the bad and the ugly 🔗 https://t.co/c5ELfHUZew (access via your free My PCR account) Watch the replay 📺 of this practical session to learn how to: 🟣Discover how to select suitable patients for #TEER 🟣Tackle

PURPOSE study published in this issue of JACC Cardiovascular Interventions with accompanying editorial @JACCJournals

In patients with RV impairment undergoing #TEER for SMR, titration of #GDMT to at least one-half of the target dose is associated with a 40% lower risk of all-cause death up to 6 years and should be pursued independent of comorbidities. https://t.co/TENeDBziIz #JACCINT

🌟 Exciting News! 🌟 Join us at Tricuspid Intervention UK on 20 September at the @RCPhysicians, London, with guest speaker Prof. Rebecca Hahn from Columbia University, NYC. Dive into the latest in tricuspid valve interventions with case reviews, evidence evaluation, and

First case of TMVR with AltaValve for our group today at Timone Hospital Marseille ! 👍🏻🙏 New option for our patients with MR not candidate for both TEER and surgery 💪🏻 ⁦@deharo_pierre⁩ ⁦@modine_thomas⁩ ⁦@nicolasdumonte1⁩ ⁦@aphm_actu⁩ ⁦@PCRonline⁩